Joleen Masschelein

2.6k total citations
31 papers, 731 citations indexed

About

Joleen Masschelein is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Joleen Masschelein has authored 31 papers receiving a total of 731 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 17 papers in Pharmacology and 9 papers in Organic Chemistry. Recurrent topics in Joleen Masschelein's work include Microbial Natural Products and Biosynthesis (17 papers), Genomics and Phylogenetic Studies (9 papers) and Plant-Microbe Interactions and Immunity (5 papers). Joleen Masschelein is often cited by papers focused on Microbial Natural Products and Biosynthesis (17 papers), Genomics and Phylogenetic Studies (9 papers) and Plant-Microbe Interactions and Immunity (5 papers). Joleen Masschelein collaborates with scholars based in Belgium, United Kingdom and Australia. Joleen Masschelein's co-authors include Gregory L. Challis, Matthew Jenner, Rob Lavigne, Piet Herdewijn, Ling‐Jie Gao, Wesley Mattheus, Emmanuel L. C. de los Santos, Guido Volckaert, Bart Landuyt and Chris W. Michiels and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Joleen Masschelein

29 papers receiving 727 citations

Peers

Joleen Masschelein
Haotong Chen United States
Prakash Masurekar United States
Yolande A. Chan United States
Michael W. Mullowney United States
Haotong Chen United States
Joleen Masschelein
Citations per year, relative to Joleen Masschelein Joleen Masschelein (= 1×) peers Haotong Chen

Countries citing papers authored by Joleen Masschelein

Since Specialization
Citations

This map shows the geographic impact of Joleen Masschelein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joleen Masschelein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joleen Masschelein more than expected).

Fields of papers citing papers by Joleen Masschelein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joleen Masschelein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joleen Masschelein. The network helps show where Joleen Masschelein may publish in the future.

Co-authorship network of co-authors of Joleen Masschelein

This figure shows the co-authorship network connecting the top 25 collaborators of Joleen Masschelein. A scholar is included among the top collaborators of Joleen Masschelein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joleen Masschelein. Joleen Masschelein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rodriguez‐Villalobos, Hector, Hans Gerstmans, Joleen Masschelein, et al.. (2025). Multiplexed bacteriocin synthesis to combat and prevent antimicrobial resistance. Communications Biology. 8(1). 1246–1246. 1 indexed citations
2.
Lescrinier, Eveline, et al.. (2025). Investigating the structure-activity-relationship of diaryl ether-based paFabV inhibitors: A path to novel antibacterials. European Journal of Medicinal Chemistry. 296. 117782–117782. 1 indexed citations
3.
Masschelein, Joleen, et al.. (2025). CAGEcleaner: reducing genomic redundancy in gene cluster mining. Bioinformatics. 41(7).
4.
Cusumano, Antonino, et al.. (2025). The plant-beneficial fungus Trichoderma harzianum T22 modulates plant metabolism and negatively affects Nezara viridula. BMC Plant Biology. 25(1). 615–615. 1 indexed citations
5.
Boon, Maarten, et al.. (2025). Non-model bacteria as platforms for endogenous gene expression in synthetic biology. Nature Reviews Bioengineering. 4(1). 67–81. 1 indexed citations
6.
Gerstmans, Hans, et al.. (2024). Bacillus subtilis as a host for natural product discovery and engineering of biosynthetic gene clusters. Natural Product Reports. 41(7). 1113–1151. 24 indexed citations
7.
Masschelein, Joleen, et al.. (2024). Exploring the selectivity of cytochrome P450 for enhanced novel anticancer agent synthesis. Faraday Discussions. 252(0). 69–88.
8.
Bircham, Peter W., Anna Zimmermann, Peter De Rijk, et al.. (2024). Combinatorial optimization of gene expression through recombinase-mediated promoter and terminator shuffling in yeast. Nature Communications. 15(1). 1112–1112. 18 indexed citations
9.
Persoons, Leentje, Christopher Williams, Dirk Daelemans, et al.. (2023). Polyketide Synthase‐Mediated O‐Methyloxime Formation in the Biosynthesis of the Oximidine Anticancer Agents. Angewandte Chemie International Edition. 62(34). e202304476–e202304476. 7 indexed citations
10.
Kosol, Simone, Angelo Gallo, Daniel Griffiths, et al.. (2019). Structural basis for chain release from the enacyloxin polyketide synthase. Nature Chemistry. 11(10). 913–923. 41 indexed citations
11.
Masschelein, Joleen, Paulina K. Sydor, Christian Hobson, et al.. (2019). A dual transacylation mechanism for polyketide synthase chain release in enacyloxin antibiotic biosynthesis. Nature Chemistry. 11(10). 906–912. 26 indexed citations
12.
Song, Lijiang, Joleen Masschelein, Irene Papa, et al.. (2019). Pentamycin Biosynthesis in Philippine Streptomyces sp. S816: Cytochrome P450-Catalyzed Installation of the C-14 Hydroxyl Group. ACS Chemical Biology. 14(6). 1305–1309. 17 indexed citations
13.
Song, Lijiang, Matthew Jenner, Joleen Masschelein, et al.. (2017). Discovery and Biosynthesis of Gladiolin: A Burkholderia gladioli Antibiotic with Promising Activity against Mycobacterium tuberculosis. Journal of the American Chemical Society. 139(23). 7974–7981. 74 indexed citations
14.
Cui, Chengsen, Paul D. Walker, Shu‐Shan Gao, et al.. (2017). Elucidation of the relative and absolute stereochemistry of the kalimantacin/batumin antibiotics. Chemical Science. 8(9). 6196–6201. 17 indexed citations
15.
Jenner, Matthew, Joleen Masschelein, Yousef Dashti, et al.. (2016). Biosynthesis of a 'fungal' peptide antibiotic by Burkholderia gladioli. Planta Medica. 81(S 01). S1–S381. 2 indexed citations
16.
Song, Lijiang, et al.. (2015). Systematic analysis of the kalimantacin assembly line NRPS module using an adapted targeted mutagenesis approach. MicrobiologyOpen. 5(2). 279–286. 1 indexed citations
17.
Masschelein, Joleen, Wesley Vermaelen, Eveline Lescrinier, et al.. (2014). A combination of polyunsaturated fatty acid, nonribosomal peptide and polyketide biosynthetic machinery is used to assemble the zeamine antibiotics. Chemical Science. 6(2). 923–929. 34 indexed citations
18.
Masschelein, Joleen, Wesley Mattheus, Ling‐Jie Gao, et al.. (2013). A PKS/NRPS/FAS Hybrid Gene Cluster from Serratia plymuthica RVH1 Encoding the Biosynthesis of Three Broad Spectrum, Zeamine-Related Antibiotics. PLoS ONE. 8(1). e54143–e54143. 63 indexed citations
19.
Mattheus, Wesley, Joleen Masschelein, Ling‐Jie Gao, et al.. (2010). The Kalimantacin/Batumin Biosynthesis Operon Encodes a Self-Resistance Isoform of the FabI Bacterial Target. Chemistry & Biology. 17(10). 1067–1071. 28 indexed citations
20.
Mattheus, Wesley, Ling‐Jie Gao, Piet Herdewijn, et al.. (2010). Isolation and Purification of a New Kalimantacin/Batumin-Related Polyketide Antibiotic and Elucidation of Its Biosynthesis Gene Cluster. Chemistry & Biology. 17(2). 149–159. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026